510(k) K982245
K982245 is an FDA 510(k) premarket notification submitted by Biosite Incorporated for the device "TRIAGE,PARASITE PANEL, TRIAGE CRYPTOSPORIDIUM AND ENTAMOEBA HISTOLYTICA, TRIAGE CRYPTOSPORIDIUM AND GIARDIA LAMBLIA". The FDA issued a decision of Substantially Equivalent on Oct 6, 1998. The device falls under product code MHI (Giardia Spp.), a Class II device regulated under 21 CFR 866.3220. Biosite Incorporated has 45 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Oct 6, 1998
- Date Received
- Jun 26, 1998
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Giardia Spp.
- Device Class
- Class II
- Regulation Number
- 866.3220
- Review Panel
- MI
- Submission Type
- 510(k) Exempt
Need the full FDA record for Biosite Incorporated? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.